G2TT
来源类型Working Paper
规范类型报告
DOI10.3386/w28071
来源IDWorking Paper 28071
Internal Deadlines, Drug Approvals, and Safety Problems
Lauren Cohen; Umit Gurun; Danielle Li
发表日期2020-11-16
出版年2020
语种英语
摘要Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly more adverse effects, including more hospitalizations, life-threatening incidents, and deaths – particularly, drugs most rushed through the approval process. These patterns are consistent with a model in which regulators rush to meet internal production benchmarks associated with salient calendar periods: this “desk-clearing” behavior results in more lax review, leading both to increased output and increased safety issues at particular—and predictable—periodicities over the year.
主题Health, Education, and Welfare ; Health ; Other ; Law and Economics ; Development and Growth ; Innovation and R& ; D ; Economic Systems
URLhttps://www.nber.org/papers/w28071
来源智库National Bureau of Economic Research (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/585745
推荐引用方式
GB/T 7714
Lauren Cohen,Umit Gurun,Danielle Li. Internal Deadlines, Drug Approvals, and Safety Problems. 2020.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
w28071.pdf(3161KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Lauren Cohen]的文章
[Umit Gurun]的文章
[Danielle Li]的文章
百度学术
百度学术中相似的文章
[Lauren Cohen]的文章
[Umit Gurun]的文章
[Danielle Li]的文章
必应学术
必应学术中相似的文章
[Lauren Cohen]的文章
[Umit Gurun]的文章
[Danielle Li]的文章
相关权益政策
暂无数据
收藏/分享
文件名: w28071.pdf
格式: Adobe PDF
此文件暂不支持浏览

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。